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Cannabis use and mental health problems are highly prevalent among Canadian youth. While 
repercussions associated with cannabis are ubiquitous throughout the population, youth are at an 
increased risk as the brain is exceptionally susceptible to adverse effects during this stage of development. 
Youth are at a disproportionate risk for addiction, developing a cannabis use disorder, depression, anxiety 
and psychosis. Moreover, the risk of developing a substance use problem is doubled in people with 
mental illness compared to the general population, whereby at least 20% of people with a mental illness 
have a co-existing substance use problem. Gaps remain within the literature that explore how the effects 
of positive wellbeing, in the presence or absence of mental illness, can serve as a protective measure 
against cannabis use.  
 
The objective of my thesis was to examine if depression or anxiety were associated with youth 
cannabis use; and investigate whether flourishing moderates these associations. My approach was guided 
by the differential susceptibility framework and used a cross-sectional analysis of the mental health 
module pilot data collected in year 5 (Y5[2016-2017]) of the COMPASS study. Data from 8,179 grades 9-
12 students were collected from 10 secondary schools in Ontario and British Columbia, Canada. 
Participants were included based on a complete case analysis for a total of 8,040 students being eligible 
participants. Self-report questionnaires were used to assess symptoms of depression [CESD-R-10], 
anxiety [GAD-7], flourishing [Deiner’s Flourishing Scale] and cannabis consumption using measures that 
assess cannabis ever use and frequency of use. Logistic regression analysis (binary and ordinal) and 
product-term interactions were used to examine the associations between mental health and youth 
cannabis use, and the potential moderating effect(s) of flourishing.  
 
In my sample, 33% of participants had ever used cannabis, 51% and 38% reported elevated 
depressive and anxiety symptoms, respectively. Associations between depression, anxiety, and cannabis 
use were no longer significant when flourishing was added to the models. In addition, there was no 
evidence suggesting a moderating effect of flourishing as all interactions were not statistically significant. 
Instead, robust associations were found between flourishing and cannabis use. Indicators of mental 
wellbeing, such as flourishing, appear to be associated with a lower likelihood of cannabis use, even after 
controlling for depression and anxiety. Results suggest prevention strategies for youth cannabis use 
should aim to foster mental wellbeing among all youth, rather than exclusively targeting those 
experiencing mental health problems. Future longitudinal studies should test the sequential relationship 
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SECTION ONE: Introduction 
 
Cannabis is the most widely used illicit drug by young people, where nearly 1 in 4 Canadian 
youth between the ages of 15 and 17 have experimented with cannabis at least once in their lifetime (1). 
As we move closer to the legalization of cannabis in Canada (July 2018), many concerns have been 
expressed pertaining to new regulations and the impact this may have on youth. Although youth will not 
be of legal age to purchase cannabis (must be 18 years and older under the federal law), research has 
demonstrated that increased use among youth populations is probable (2–4).  
 
Prior to this legislation being enacted, important questions remain about current cannabis use 
among Canadians and correlations to other health-related issues common among youth (e.g., depression, 
anxiety, co- occurring substance use). Of particular concern to many health promotion and public health 
professionals is the link between cannabis use and mental illnesses, specifically depression and anxiety. 
Research has highlighted a presumable interaction between cannabis use and mental health (5–9).There 
is, however, limited knowledge related to the patterns of youth cannabis use and possible factors 
associated with initial uptake and the frequency of use. A greater understanding of how mental health and 
aspects of wellbeing are correlated with cannabis use can inform targeted prevention strategies, and in 
turn, minimize possible health consequences that may accompany the legalization of cannabis in Canada. 
 
To successfully implement new regulatory laws on cannabis, further research is required, 
particularly regarding how to appropriately target youth who are at high risk for using cannabis. The 
COMPASS study is a prospective cohort study utilizing a quasi-experimental design to collect and 
evaluate various youth health behaviours (e.g., diet, physical activity, obesity, cannabis, alcohol, tobacco, 
sedentary behaviours and mental wellbeing) from a sample of Canadian secondary students (10). During 
the 2016/2017 data collection, a newly developed module of COMPASS focused on mental health was 
implemented in a pilot sample of schools. This project will examine the association between mental 
health and cannabis use among youth using the first wave of the pilot data from the Mental Health 





SECTION TWO: Literature Review 
 
2.1 The importance of understanding cannabis use patterns  
 Greater knowledge and exploration of cannabis use patterns and trends is essential for good 
policy creation that will help guide possible outcomes and minimize risk through evidence-based decision 
making. Cannabis use has been associated with considerable harmful effects resulting in addiction (11), 
cognitive impairments (12,13), impaired motor function (14–17) and poor mental wellbeing (18–25). 
While cigarette smoking prevalence continues to decrease (26), reported prevalence of regular cannabis 
use has steadily increased to almost 3% of Canadians (age 15+) being daily users and may soon surpass 
daily tobacco use (27). This trend has also been demonstrated in a U.S. sample of grade 12 students (28). 
Regular cannabis use during adolescence is of particular concern given the continued rapid and extensive 
brain development during this life stage (12,13) and the potential lifelong consequences that are 
associated with use in with this age group (14). 
 
Observed trends of cannabis use have been found to cluster by demographics, geography, mental 
wellbeing and other health behaviours. According to Statistics Canada, past-year and daily cannabis users 
were most likely to be male and between the ages 18-24 years old (1). Geographical and regional 
differences of cannabis use patterns have been observed, with Atlantic (Nova Scotia) and Western 
(British Columbia) provinces reporting the highest past-year use compared to other provinces within 
Canada (1). Variability was also evident in urban dwellers, which were the most common past year 
cannabis users relative to rural communities (1). Indigenous (Nunavik) youth are at a particularly high 
risk where approximately two-thirds of 15-19 year olds reported past year use in 2010 (29). Cannabis use 
in both youth and adults has been robustly correlated with mental illness (30–33) and is particularly 
prevalent in individuals with schizophrenia and psychosis (18–22),  anxiety (34,35), and depression (23–
25). However, limited research has explored how flourishing may moderate this link as a potential 
protective factor.  Other risky health behaviours as such tobacco and alcohol use (36,37) and early sexual 
activity (37) and impaired driving (14) are found to co-occur with cannabis use and therefore 
demonstrates the demand for our understanding of this correlation. To better inform policy, it is important 
to recognize how public perception of cannabis may change after legalization, and how to best prepare for 
latent consequences associated with the legalization of cannabis. 
 
The role of cannabis as a gateway drug remains an important political and public health issue 
within Canada. Theories state that psychoactive component in cannabis, tetrahydrocannabinol (THC), and 
the dopamine reaction that follows its use may prime the brain for addiction (38) and enhanced responses 
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to other drugs (39). This cascading effect may be a result of substance users having a higher propensity 
for sensation seeking (40) or subsequent social interactions (41). As previously described, cannabis use 
remains problematic in subpopulations and therefore understanding patterns related to use and misuse is 
relevant for policy makers involved with the creation and modification of the Cannabis Act going 
forward.  
 
2.2 Harms of cannabis use  
 Short and long term cannabis use has been associated with number of negative health outcomes 
including acute, chronic and social adversities (42). Use can lead to the development of problematic 
uptake or addiction and some groups are disproportionately susceptible to cannabis use disorders. 
Research suggests that 30% of cannabis users are problematic users (43) and those who begin using 
before the age of 18 are up to seven times more likely to develop a cannabis use disorder (44). High 
vulnerability to addiction in adolescents is hypothesized to be related to the active development of the 
brain (11). However, unknowns about physical and psychological harms associated with cannabis use is 
persistent throughout the literature and demonstrates the need for further exploration (45). 
 
2.2.1 Acute Harms of Cannabis  
Cannabis smoking can produce acute impairments to lung function and lead to serious or fatal 
injury. Inflammation and resistance of the airways as well as lung hyperinflation are associated with 
regular cannabis use (46) and may compromise immune function leading to respiratory infection or 
pneumonia (47). Moreover, cannabis is the most commonly used illicit drug while driving impaired and 
has become progressively more prevalent in reported fatal accidents (14). In turn, drugged driving has 
become an important public health issue within Canada with a particular focus on adolescents (14). Youth 
propensity for sensation seeking was directly related to substance use; this relationship is suggestive that 
sensation seekers have an increased risk of motor vehicle accidents (48). Research has linked non-alcohol 
substances, particularly cannabis, to impaired reckless driving and accidents with fatal outcomes (15–17). 
Additionally, there is currently no good test to identify drivers under the influence of cannabis, making 
this difficult to monitor.  
 
2.2.2 Chronic Harms of Cannabis  
Chronic effects that have been observed in relation to cannabis use include respiratory ailments, 
mental illness, as well as cognitive and intellectual impairments. Regular use of cannabis is suggestive of 
having detrimental acute and long term effects on the lungs and airways (46). Acute harms of cannabis 
smoking coincide with regular cannabis smokers being more likely to report chronic bronchitis (46). 
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Numerous studies have shown cannabis use and the risk of schizophrenia and psychosis (18–22) appears 
to be dose-dependent where higher risk of schizophrenia is predicted by the earlier age of cannabis use 
(22,49). Schizophrenia usually appears in early adulthood where the risk is doubled in heavy cannabis 
users (50). Moreover, the risk of psychosis is increased by an approximate 40% in youth cannabis users 
and also demonstrates a dose-response relationship with the frequency of use (32,51). Regular cannabis 
use by adolescents has also been found to increase the risk of depression (23,24) and exacerbate 
symptoms of depression and anxiety (25). Research shows that compared to non-users, adults who used 
cannabis twice monthly or more during their adolescence, had fewer fibers in brain regions that were 
responsible for alertness and self-conscious awareness as well as learning and memory (12) ultimately 
leading to lower IQ-test scores .  
 
Cannabis use and schizophrenia and psychosis has been robustly studied in an adolescent 
population and findings demonstrate that frequent cannabis exposure at a young age may exacerbate the 
course of illness, advancing earlier onset of a first-time episode by 2 to 6 years (52,53). Additionally, 
frequent cannabis use is correlated with an increased risk of depression and anxiety (5). A growing body 
of research suggests that adolescent cannabis use is correlated with increased rates of psychological 
distress and anxiety (35). A large cohort study found a link between frequent cannabis use and the 
incidence of anxiety symptoms in young adults (34). Additionally, robust research highlights an increased 
risk of depression in cannabis users compared to non-users, and the level of risk increases with younger 
initiation and more frequent use (5,23,24,54). Patton and colleagues (5) found a dose response with the 
frequency of cannabis use predicting later depression and anxiety in adolescent girls with daily user 
presenting the highest risk. Compared to occasional users, regular cannabis use has been linked to 
significantly lower quality of life in women (55).  
 
 
2.2.3 Social Harms of Cannabis  
Cannabis use that is initiated in adolescence has been linked to lower IQ compared to adult-onset 
cannabis use and findings are suggestive of a neurotoxic effect on the developing (adolescent) brain (13). 
Compounding decreased IQ, cannabis use has also been found to impair academic performance (56–58), 
engagement (56) and aspirations (56), as well as increase the risk of dropping out of school (57,58). These 
adverse effects on brain development and functional connectivity are especially obvious in adolescent-
onset cannabis users (12). 
 
2.3 Current and future laws on cannabis use and distribution in Canada 
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 Under the Controlled Drug and Substance Act, cannabis remains a schedule II drug that is not 
permitted for recreational consumption across Canada (59). Unlicensed vendors or stores selling cannabis 
continue to be illegal and sell unregulated products that may be dangerous for consumption. Regardless of 
age, individuals purchasing and consuming cannabis for medical reasons must possess documentation 
from a health care provider and the prescription is to be filled through a licensed producer and/or 
authorized individuals (60).       
 
The Government of Canada expects to implement the Cannabis Act no later than July 2018, 
permitting recreational (non-medical) cannabis use. The proposed Act aims to create a legal framework 
that is targeted towards protecting youth by closely controlling the production, distribution, sale and 
possession of cannabis (61). Any person under the age of 18 would be prohibited from using or 
possessing cannabis. Federally controlled access will allow adults (18 years or older) to legally possess 
≤30 g, share ≤30 g with others who are of legal age, purchase cannabis through a licensed retailer and 
cultivate up to 4 cannabis plants (61). In addition to the restrictions proposed by the federal government, 
regulatory laws may vary for different jurisdictions as provincial governments may decide to increase 
restrictions or supplement the minimal federal conditions. For example, Ontario has increased the 
minimum age to purchase and consume cannabis at 19 years old (62). 
 
2.4 Cannabis use in Canadian youth  
According to the World Health Organization, 33.3% of Canadian youth have used cannabis at 
least once by the age of 15 and are the highest ranked users across 43 North American and European 
countries and regions (63). Nearly two-thirds of Indigenous youth reported past year use (29) and 20% of 
Ontario youth reported using cannabis at least once a month (2). In Ontario high school students, age is an 
evident risk factor in substance use uptake with current cannabis use increasing by 160% between grade 9 
and 12, where students in grade 12 reported the highest frequency of use (2,64). 
 
2.4.1 Trends and patterns of substance use in youth: tobacco and alcohol literature  
 Reflecting on the well-established domain of tobacco literature, many researchers have defined 
critical stages of smoking and the multiple social, psychological and biological factors that are associated 
with different stages, particularly in youth (65). When considering the progression of smoking, research 
highlights important differences in adolescents who have never smoked, who have contemplated 
smoking, who have ever tried smoking and various levels of frequency ranging from experimenting to 
daily use (65). Adolescents who have never tried smoking likely have no desire to smoke and are resistant 
or unaware to the appealing reasons to try (65). The initiation or ever use of cigarettes is characterized by 
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being susceptible to peer pressure and is motivated by academic achievements and social engagement 
(65). Lastly, increases in frequency of smoking are categorized into three stages: “experimenter”, 
“regular” and “daily smoker”. Adolescents who classify as “experimenters” will more commonly draw 
attention to the positive aspects of smoking and may self-identify as a smoker. The transition into 
“regular” smoking is demonstrated when negative aspects originally associated with smoking become 
positively perceived. This stage is associated with the greatest physiological and stimulating reaction (65) 
where the user moves past sporadic smoking to regular or weekly uptake. Both initial levels and 
frequency rate of substance use in an adolescent population have been related to age, gender, family and 
peer factors (66–68). Substance use trajectories were predicted by inter-individual differences and 
attitudes, where positive perceptions were related to any stage of smoking (69). The differences in 
characteristics and corresponding attitudes of each smoking stage illustrates the importance of 
distinguishing between types of users in substance use research.  
 
The stages of smoking defined previously can also be applied to cannabis use. Cannabis research 
has demonstrated outcomes in various domains (e.g., school performance, mental health) that are directly 
associated with the frequency of cannabis use. Compared to non-users, women who used cannabis 
occasionally had higher odds of reporting low levels of accomplishment and vigilance as a result of 
emotional problems (55). Academic ambitions, school engagement and dropout rates have also been 
linked to cannabis use and frequency. One study found that students who had used cannabis at any 
frequency while attending high school were 2.3 times more likely to drop out compared to students who 
had never used cannabis (58). A study in Ontario youth showed that cannabis ever use was associated 
with academic disengagement and poor school performance (56). Similar to the stages of smoking, 
cannabis ever use and frequency of use among ever users are important measures to consider in this 
domain of research.      
     
 
2.4.2 Neuropathology of cannabis on the developing brain  
 Brain development is an active process throughout adolescence and is guided by both personal 
experiences and environmental factors (70). Compared to adults, whose brains are developed, exposure to 
cannabis during adolescence is particularly concerning given the chemical and structural changes 
associated with cannabis use and the susceptibility of the brain during neurological development (71,72). 
The psychoactive component of cannabis, THC, artificially stimulates cannabinoid receptors and the 
endocannabinoid system and can lead to perceptual and emotional changes (73). Cannabis use in 
adolescence has been found to result in structural changes within the brain leading to lower brain volumes 
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and white matter, different folding patterns, thinning of the cortex and low levels of neural connectivity 
(73). Research also shows that youth who use cannabis regularly, demonstrate increased neural activity 
where the brain must overcompensate to perform tasks (74). While most research has demonstrated 
important neuropathological changes in heavy cannabis users, recent findings show that similar changes 
are evident in infrequent users as well and can impact fundamental brain regions involved with emotional 
and behavioural regulation (75). Moreover, even occasional use of cannabis has been shown to induce 
transient psychotic reactions in healthy individuals (76). 
 
2.5 Mental health in Canadian youth  
 Canadians between the ages of 15 and 24 experience mental illness more commonly than any 
other age group (77) by which 70% of mental illnesses will emerge by adolescence (78). The two most 
common mental illnesses are depression and anxiety (78). In Ontario high school students, 34% report 
moderate to serious levels of psychological distress, symptoms of depression and/or anxiety, and 14% of 
these students report these symptoms at a severe level (79). Medical visits related to youth mental health 
nearly doubled in the past two decades (80) demonstrating the vastness of human and economic burden 
resulting from mental illness (81). Mental health is directly related to physical health and people with a 
mental illness are at a much higher risk for developing a long term medical condition (82).    
 
2.5.1 The mental illness and health continua  
Mental health is an important part of overall wellbeing. However, it is important to recognize the 
distinction between mental health and illness whereby the absence of mental illness does not necessarily 
indicate mental wellbeing. Statistics Canada states that one third of Canadians will experience one of the 
six main mental illnesses (including substance use disorders) in their lifetime (77). Mental illnesses, such 
as depression, anxiety and schizophrenia, are diagnosed conditions that alter our thinking, mood and 
behaviours, and impact how we function in our lives (78). Mental health is a positive concept that relates 
to our ability to enjoy and manage life and is more than the absence of mental illness (83), but rather a 
sense of emotional and spiritual wellbeing (84). Research shows that mental health and illness should be 
regarded as separate yet interconnected concepts that are to be looked at as two related continua, the 
mental health continua and the mental illness continua (refer to Appendix B for diagram and description).  
 
2.5.2 Depression 
According to the World Health Organization, depression is recognized as the leading cause of 
disability worldwide (85). Depression is characterized by feelings of sadness and a lack of interest in 
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daily activities for more than two consecutive weeks (85). It is usually accompanied by impaired social 
and work function, and changes in sleep, activity, concentration and mood (85). While depression can 
occur at any life stage, onset peaks during late adolescents (86) and rates have been found to be the 
highest among youth aged 15-24 (77). Research shows that depression is more common and persistent in 
females than males (87,88). This is consistent among youth as the prevalence for depression in females 
(ages 15-24) is nearly double the prevalence in males (89).  
 
2.5.3 Anxiety  
Generalized anxiety disorder (GAD) is defined as persistent worry that is exaggerated and 
unrealistic and can hinder social and occupational functioning (90). It is the most common anxiety 
disorder, affecting approximately 3% of the general population (91,92) and is the most prevalent mental 
illness in youth as GAD often begins during childhood (90). Anxiety related disorders were consistently 
the most common reason for ED visits (91) and have resulted in serious economic burden (81). In 
addition to economic burden, anxiety disorders can result in significant human burden and cause 
impairments to quality of life that have been found to be comparable to that which result from major 
depressive disorder (81). Of those with GAD, 52.6% also met the criteria for depression (77). The co-
occurrence of the two illnesses is a commonly found pattern in other research (93,94) and provides 
rationale for depression and anxiety to be examined separately as well as co-occurring diseases. 
 
2.5.4 Mental Wellbeing and Flourishing  
 Mental wellbeing has been operationalized to include measures of emotional, psychological and 
social wellbeing and represents the concept of flourishing (95,96). As previously outlined, the absence of 
mental illness does not imply good mental health and positive mental health (wellbeing) and mental 
illness can coexist (97). Flourishing is defined as a state of overall wellbeing and the presence of positive 
mental health (97). The absence of flourishing has been used to predict the incidence and future risk of 
mental illness (98) where one study found that probability of all-cause mortality in adults increased in the 
absence of flourishing (100). While flourishing individuals have been found to function better than all 
others, just one fifth of the U.S. adult population is flourishing (97,101–104). Statistics Canada estimates 
that in 2012, 72.5% of Canadians ages 15 or older did not meet the criteria for a mental illness and 
reported flourishing, categorizing them as having “complete mental health” (84). Complete mental health 
was positively associated with good physical health and strong spirituality whereas people living in urban 
environments and who are of low income status were less likely to report complete mental health. 
Additionally, flourishing is much less common in people with a mental illness and only 4.5% of these 




2.6 Mental health and youth cannabis use  
 While repercussions associated with cannabis can occur at any age, youth are at an increased risk 
as the brain is exceptionally susceptible to adverse effects during this stage of development. As 
highlighted above, youth are at a disproportionate risk for addiction, developing a cannabis use disorder, 
depression, anxiety and psychosis. Research shows that the risk of developing a substance use problem is 
doubled in people with mental illness compared to the general population. At least 20% of people with a 
mental illness (105) have a co-existing substance use problem and this risk increases to 50% in people 
with schizophrenia (106). Moreover, people with substance use problems are three times more likely to 
have a coexisting mental illness (106).   
 
2.6.1 Neurotoxic effect of cannabis use and mental illness  
The psychoactive component of cannabis, THC, artificially stimulates cannabinoid receptors 
within the endocannabinoid system interfering with the regulatory capacity of this system (73). Abnormal 
functioning of the endocannabinoid system may be directly related to the development of mental illness 
through long term damages to brain function. Current research suggests that the detrimental effects 
associated with cannabis use in relation to depression and anxiety may be linked to decreased activity of 
the endocannabinoid system, inhibition of endogenous cannabinoid production and cannabinoid receptor 
expression (107,108). Blockage of the cannabinoid receptor have been shown to induce feeling of 
depression and anxiety (108); individuals who are genetically more vulnerable to mental illnesses have 
been found to be at an increased risk to the adverse effects associated with cannabis use (53,109). 
Although research suggest a neuropathological link between cannabis use and mental illness, findings are 
inconsistent and require continued study.    
 
2.6.2 Gaps in current cannabis use and mental illness research  
Several studies have linked frequent cannabis use with an increased risk of depression and 
anxiety (5). However, opposing studies have demonstrated insignificant correlations or a decrease in the 
relationship after controlling for important confounding variables and demographic factors (110,111). 
Although research has suggested a strong association between daily cannabis use and mental illness, 
evidence is inconsistent and demonstrates the need for further rigorous exploration (34,112).  
 
While existing research suggests that mental impairments develop as a result of cannabis use and 
not the reverse (5,9), contrasting epidemiological evidence shows that cannabis is used disproportionately 
by individuals with mental health disorders (6) and that mental distress directly contributes to the etiology 
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of a cannabis use disorder (6). Much of the available research that considers cannabis use as result of a 
previous mental illness have looked at PTSD (6), externalized and internalizing behaviours (7) and social 
deviance (8). Limited research exists exploring the early onset of cannabis use with co-occurring 
depression and/or anxiety. It is likely that factors triggering mental illness may also contribute to cannabis 
use behaviours and confounding variables that may go overlooked add to the difficulty in establishing the 
direction of the causal pathway. Moreover, the author is unaware of any studies that have examined how 
flourishing may interact with the association between depression and/or anxiety and cannabis use in 
youth.  Given the contrasting evidence for both arguments, and the gaps in literature that explore the 
protective elements of mental wellbeing, future research within this domain is required. 
 
2.7 Differential susceptibility model 
 The differential susceptibility hypothesis (model) is a framework used to interpret psychological 
findings. The model suggests that individuals vary in susceptibility to experiences whereby biological and 
environmental factors guide development and emotional affect relative to how plastic a person is (113). 
The differential susceptibility hypothesis examines positive or negative events and the variance in 
individual susceptibility to both supportive and adverse conditions (113). That is, some people are more 
sensitive than others to given experience and those who are highly susceptible will be more affected by 
both negative and positive experiences. These individuals are seen to be most malleable. This theory 
embodies the concepts of the mental illness and health continua (see section 2.5.1) illustrating individuals 
with a mental illness can still display optimal mental wellbeing. That is, those with a mental illness may 
remain plastic where they are particularly sensitive to positive conditions (i.e., optimal mental wellbeing). 
Since this study explores the influence of both positive and negative affect in cannabis use patterns, the 
application of a differential susceptibility framework will allow us to examine malleability among 
students who are depressed and anxious, using flourishing as a plasticity factor.  
 
2.8 Covariates of interest 
 According to previous research, cannabis is disproportionately used by specific subpopulations 
which will guide the selection for variables to control for in the analysis.    
 
2.8.1 Demographic Characteristics   
 Research has shown that cannabis use increases with age (2,114). Grade has been used as a proxy 
for age as this is a more relevant measure for school stakeholders. Sex has also been found to be 
associated with cannabis use and mental health. Females are at greater risk for depression and anxiety 
disorders than males (77,89), and males report higher rates of cannabis use (2,27,114) and substance use 
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disorders (77). Ethnic differences have been previously observed in cannabis use trends, where White 
youth are less likely to use cannabis than other races (115) and Indigenous youth are more likely to report 
ever trying cannabis and being regular users compared to non-Indigenous youth (116). Amount of weekly 
spending money has been positively associated with substance use in youth (117). Weekly spending 
money is a good measure to represent socioeconomic status which has been shown to be a strong 
predictor for substance use (118).  
 
2.8.2 Behavioural Characteristics  
Cannabis use has been robustly linked to the use of other substances, particularly alcohol and 
tobacco. Binge drinking and smoking among youth is strongly associated with cannabis use and cross-
sectional (119–121) and longitudinal (26,27,36,122–124) studies have demonstrated a clustering of these 





SECTION THREE: Study rationale and Research questions 
 
3.1 Study Rationale 
 
 The proposed Cannabis Act has been designed to monitor and control the production, 
distribution, sale and possession of cannabis in Canada. This new legislation is expected to be 
implemented no later than July 2018 (61), and although the legalization of cannabis has been widely 
supported by the public (125), important knowledge about use is not yet available. Recently, various U.S. 
states, including Colorado, California and Washington, have implemented new legislations regarding the 
recreational use of cannabis. Research has found decriminalization of cannabis to be associated with 
permissive attitudes among youth leading to a decrease in risk perception (126). Additionally, youth have 
reported an increase in perception of easy access to cannabis (127). Results from literature that explore 
trends relative to the decriminalization of cannabis, provide empirical evidence that suggest the 
commercialization of cannabis may be a risk factor for increases in youth uptake and future drug 
dependence (126,128). 
 
A link between cannabis use and mental illness has been clearly identified in current literature, 
with much of the evidence focused on psychotic disorders, depression and anxiety. The risk of developing 
psychosis has been directly related to cannabis use and has been well established by robust research (51). 
A longitudinal, population based study found that individuals using cannabis at baseline were almost 
three times more likely to display symptoms of psychosis at the three year follow up period and exhibited 
a dose-response relationship between cannabis use and psychotic reactions (49) where even occasional 
use has been found to induce transient psychosis in healthy individuals (76). In addition to psychosis, one 
study found that daily and weekly cannabis use in adolescents significantly increased the odds of 
depression and anxiety in adult women (5). Longitudinal and cross-sectional evidence has shown long 
term exposure to cannabis, high frequency of use (5,33,129), as well as a younger age of onset for 
cannabis use (5,32) are important risk factors in developing a mental illness. Pathological changes in the 
brain, similar to heavy cannabis use, has also been observed in infrequent users (75). 
 
Studies exploring patterns associated with the use of e-cigarettes and synthetic cannabinoids have 
found that ever users exhibit a higher propensity to engage in risky behaviours (e.g., drug and alcohol use, 
tobacco use, sexual behaviours) than never users of these substances (130,131). This trend highlights the 
importance of establishing the differences between the two cohorts as ever users of cannabis have an 
“experimenter’s profile” for sensation seeking and will likely have a greater disposition to engage in risky 
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behaviours than youth who have never used cannabis. Additionally, those who use cannabis daily will 
have distinct outcomes compared to occasional users. The frequency of cannabis use has been shown to 
be an important measure contributing to overall wellbeing (5), academic ambitions (56) and pathological 
changes within the brain (73). One study found that the frequency of cannabis use in adolescent girls 
predicted later depression and anxiety and the risk increased with higher frequency of use (5). Prevention 
strategies in the past have primarily focused on the process and predictors of problem behaviour. These 
evolving approaches and have been criticized for focusing too closely on antecedent predictors while 
overlooking co-occurring problems and factors that promote health (132). Positive youth development has 
been largely embedded in preventing problematic behaviours (133,134) and have the ability to buffer 
against many risk factors for negative outcomes (98,135). To explore positive youth development and 
how these factors may offset mental health trajectories as a function of cannabis use, I have included 
flourishing as a moderating measure. 
 
While there is a large body of evidence exploring the relationship between cannabis use and 
mental illnesses, inconsistencies within the literature and contrasting findings indicate the importance of 
continued research. As well, critical knowledge gaps remain that consider how positive aspects of 
wellbeing, such as flourishing, may co-exist and serve as a protective measure against the use of cannabis 
in high risk populations (i.e., youth with poor mental health or with mental illnesses). Cannabis use and 
some mental illnesses have been negatively associated with flourishing levels (99), however research has 
not yet considered the role of flourishing in youth with mental illness and co-occurring cannabis use. This 
author is not aware of any studies that have examined how flourishing may offset the use of cannabis in 
youth experiencing depression and/or anxiety. My research aims to generate knowledge that is necessary 
for creating evidence-based policies and programs, and add to existing literature while introducing a level 
of novelty by exploring the protective elements of mental wellbeing. 
 
COMPASS is a robust research platform designed to evaluate youth health behaviours over time 
and foster practice-based evidence that is used to guide program and policy creation (10). COMPASS has 
recently developed and tested a new mental health module (MH-M) to be added to the original student 
questionnaire. The MH-H was first piloted in a subsample of the fifth wave (2016-2017), and in some 
Ontario and BC schools only, giving reason to the transversal nature of this study. This cross-sectional 
work will highlight possible correlations between cannabis use and mental health in youth and help guide 





3.2 Research Questions  
 
For my thesis, I explored the following research questions:  
 
Research Question 1a: Among students in Year 5 of the COMPASS MH-M Pilot study, are clinically 
relevant levels of depression and/or anxiety associated with ever use of cannabis, controlling for known 
demographic, social and behavioural correlates (e.g. sex, grade, ethnicity, spending money, truancy, binge 
drinking and smoking)? 
 
Research Question 1b: Are different levels of depression and/or anxiety associated with associated with 
ever use of cannabis? 
 
Research Question 1c: Does flourishing moderate the effect of being depressed and/or anxiety on 
cannabis ever use? 
 
Research Question 2a: Among students in Year 5 of the COMPASS study, are clinically relevant levels of 
depression and/or anxiety associated with frequency of cannabis use? 
 
Research Question 2b: Are different levels of depression and/or anxiety associated with associated with 
frequency of cannabis use? 
 
Research Question 2c: Does flourishing moderate the effect of being depressed and/or anxious on 




Research Question 1a: 
 I hypothesized that students who report relevant levels of depression and/or anxiety would more 
likely be ever users of cannabis compared to students who do not experience depression and/or anxiety. 
 
Research Question 1b:  
I hypothesized that there would be a positive association between levels of depression and/or 
anxiety and the ever use of cannabis. As levels of depression and/or anxiety increased, the likelihood of a 




Research Question 1c: 
 Based on existing evidence, I hypothesized that high flourishing would moderate the ever 
use of cannabis by reducing the observed association between cannabis ever use and depression and/or 
anxiety. Flourishing was expected to have a similar effect on students who did not indicate depression 
and/or anxiety and were expected to be less susceptible to cannabis use. 
 
Research Question 2a: 
 For the second objective, I hypothesized that relevant levels of depression and/or anxiety would 
be directly associated with the frequency of cannabis use. Students who did not report depression and/or 
anxiety were expected to be less frequent users of cannabis than students who reported depression and/or 
anxiety. 
 
Research Question 2b: 
I hypothesized that there would be a positive association between levels of depression and/or 
anxiety and the frequency of cannabis use. Least frequent users of cannabis were expected to be students 
who reported no depression and/or anxiety and the most frequent use of cannabis was to be seen in 
students reporting the highest levels of depression and/or anxiety.  
 
Research Question 2c: 
 Similarly, I hypothesized that that flourishing would provide a protective element against the 
frequency of cannabis use and act as a moderator in students who are depressed and/or anxious. A similar 
effect was expected to be observed in students who did not indicate depression or anxiety.  
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SECTION FOUR: Methodology 
4.1 COMPASS Host Study 
 
 COMPASS is a longitudinal, prospective cohort study that annually (2012-2017) collects data 
from students in grades 9 to 12 attending participating secondary schools in jurisdictions across Canada 
(10). COMPASS is the first study of its kind with a rigorous foundation to evaluate school programs, 
policies, and environmental factors that could potentially impact student health behaviours and outcomes 
over time. By implementing a quasi-experimental design that collects hierarchical data at the student, 
school and environmental level, COMPASS provides a research platform with robust internal control and 
external validity (10). Student-level data are collected through the COMPASS questionnaire – student 
survey (Cq). Individual student-level data are collected on demographics, weight status, diet, physical 
activity, sedentary behaviour, substance use, bullying, academic achievement, and mental wellbeing (see 
section 4.2. for more details). School-level data on school programs and policies related to the 
COMPASS behaviours of interest are collected through the online School Policies and Practices 
Questionnaire (SPP). The SPP is completed by the COMPASS school contact, usually most 
knowledgeable about the school environment (i.e., teacher, principal, school nurse). COMPASS also 
collects measures on the within and surrounding built environments, such as physical infrastructure, parks 
and community centres. As a prevention research system, COMPASS facilitates knowledge translation 
and exchange for participating schools by providing them with individualized health profiles, tailored 
intervention recommendations, and prevention resources through funding and/or connections via the 
schools assigned knowledge broker. Given the pilot stage of the mental health module, this current study 
will conduct a cross-sectional analysis using the student-level data (Cq) from Year 5 (2016-2017) of the 
COMPASS study. 
 
4.1.1 Study Design  
My thesis will employed a cross-sectional study design. All schools that piloted the mental health 
module (MH-M) in both British Columbia (N=5 schools) and Ontario (N=9 schools) and all students who 
completed the survey (n=8179) in Year 5 of the COMPASS study, were included in the analysis. This 
provided sufficient sample size and power to detect a correlation if one exists, and the ability to highlight 
differences between provinces. Complete-case analysis was used for all models in the proposed research 
questions. Descriptive statistics and cross-sectional analysis was conducted in the software SAS version 





4.2 The COMPASS Student Questionnaire  
 
 The COMPASS student questionnaire (Cq) includes 73 questions, inclusive of the mental health 
module piloted within a select sample in 2016-2017 (refer to section 4.2.1 below for more details). The 
Cq collects self-reported information pertaining to sociodemographic characteristics and health 
behaviours specifically related to physical activity, weight perception, healthy eating, tobacco, alcohol 
and cannabis use, bullying, sedentary behaviours, sleep, academic achievements, school connectedness 
and mental health. Items were selected to echo both science and practice-base interests (10) and are 
consistent with measures used in national surveillance tools or public health guidelines (136–138), 
demonstrating good reliability and validity (139–141). During the selected time of the data collection, 
students are given a full class period to complete the Cq and a COMPASS researcher is present to collect 
the surveys, as well as deal with any student or teacher questions. A copy of the original Cq can be found 
in Appendix A. 
 
4.2.1 Pilot Mental Health Module 
 The mental health module (MH-M) was first implemented in select Ontario and British Columbia 
schools in 2016-2017. This module included eight additional subsections about youth mental health to 
supplement the original Cq. The development of the MH-M included both quantitative (pilot testing) and 
qualitative (focus groups) approaches, and was designed based on other youth mental health research and 
government strategic priorities (142). To reflect both research and practice concerns, stakeholders (i.e., 
schools, clinicians and school boards) were involved in the creation of the tool, and focus groups were 
conducted in an Ontario school. Focus groups allowed for students (grade 9-12) to give constructive 
feedback on the propriety and comprehension of the MH-M as well as suggestions for its improvement. 
Using this feedback, revisions were made to the MH-M and an updated version has been integrated into 
the Cq for data collections. The MH-M and highlights from the focus group interviews can be found in in 
the Tech Report previously cited (142). 
 
4.3 Participants  
 
4.3.1 School Recruitment and Sampling   
 Schools and boards were purposefully selected to participate in the mental health module. All 
Ontario secondary schools within the Simcoe-Muskoka Catholic District School Board (Number of 
Schools N=5) and British Columbia (BC) secondary schools (from school boards including: Vancouver 
School Board (N=1), Sooke Board of Education (N=2), Chilliwack Board of Education (N=1) and 
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Coquitlam District School Board (N=1)) were invited to participate in the pilot testing of the MH-M. 
Specific schools were recruited to participate in the pilot stage based on expressed interests in the mental 
health data. This recruiting strategy allowed for a diversified population and comparisons across 
jurisdictions. 
 
4.3.2 Student Recruitment and Sampling  
COMPASS follows an active-information passive-consent protocol. Parents/guardians of students 
at participating schools receive information letters before the date of each annual data collection. Students 
are withdrawn from participating in the survey if guardians contact the researchers, or returned a no 
permission form to the office or homeroom teacher prior to the survey. Students can also choose not to 
participate at any point during the data collection (10). Year 5 of the student-level sample, inclusive of the 
mental health module, was 8179 students.  
 
4.3.3 Ethics 
 The COMPASS study has received ethics approval from the Office of Research Ethics at the 
University of Waterloo (ORE #: 17264). School boards, schools and students participating in the study 
have also provided permission. 
 
4.4 Measures and Operational Definitions  
 
4.4.1 Response Variables   
Cannabis Use  
To assess cannabis use, students were asked about ever use and frequency of use. For ever use of 
cannabis, respondents were asked “In the last 12 months, how often did you use marijuana or cannabis? (a 
joint, pot, weed, hash)”. The response options were: “I have never used marijuana”; “I have used 
marijuana but not in the last 12 months”; “Less than once a month;” “Once a month;” “2 or 3 times a 
month;” “Once a week;” “2 or 3 times a week;” “4 to 6 times a week;” and “Every day”. Responses were 
recoded into never users if the student had never used cannabis, and all other responses were coded as 
ever users. For frequency of use, responses were recoded into “never,” if students were never users, 
“rare/sporadic” if respondent used cannabis less than once month, “monthly” if reported use was once to 
3 times per month, “weekly” if use ranged from once to 6 times a week, and “daily. Substance use 





4.4.2 Explanatory Variables  
Depression 
Student depression was measured with the Center for Epidemiological Studies Depression Scale 
Revised (CES-D-10), a 10-item scale designed to assess self-reported depressive symptoms in adolescent 
and adult populations over a 1-week period (143–145). The scale includes items on positive and negative 
affect, somatic activity, and interpersonal relations. A four-point Likert scale is used to rate the frequency 
of symptoms experienced; higher scores (range: 0-30) indicate greater frequency of depressive symptoms 
and individuals reporting scores ≥10 are considered to be depressed (145). Depression will be coded as 
both a categorical variable and a continuous variable. This study will use scores ≥10 to establish the 
presence of depression and use a binary coding system to categorize students with and without depressive 
symptoms (control=0, depressed=1). Additionally, the level of depression will be coded for as a 
continuous variable using scores ranging from 0 to 30. Test-retest reliability for the CES-D-10 was high 
(Pearson r=0.83) (146). 
 
Anxiety  
General Anxiety Disorder-7 (GAD-7) (147) is a valid and efficient screening tool used to assess 
generalized anxiety in both clinical practice and research. The GAD-7 is a brief, self-report scale that 
describes necessary items that reflect the DSM-IV criteria for assessing GAD (147). A four-point scale is 
used to score each of the 7-items, where total scores range from 0 to 21. Scores 5-9, 10-14 and 15+ 
represent mild, moderate and severe anxiety, respectively. Anxiety will be fit as either a categorical or 
continuous variable. To be consistent with other research, this measure will be coded as binary where 
students reporting scores <10 will not be considered as having GAD and those with scores ≥10 will be 
classified as being anxious (control=0, anxious=1) (147). Anxiety as a continuous independent variable 
will have scores ranging from 0 to 21, where increasing scores will indicate higher levels of anxiety. Test-
retest reliability (intraclass correlation=0.83) of the GAD-7 is very good (147). 
 
4.4.3 Interaction Variable 
Flourishing 
 Levels of psychosocial prosperity and wellbeing among students were measured 
using the Diener Flourishing Scale (FS) (148). The FS is a brief, 8-item scale that surveys the domains of 
human functioning, including information about relationships, feelings of competence, and perceptions of 
leading a purposeful life (148). To match the format of the original Cq and maintain suitability for large 
school-based studies among youth (142), the original 7-point likert scale was cut down to a 5-point 
response scale with total scores ranging from 8 to 40. All item statements are positively framed, where 
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high scores denoting a strong agreement with all items will reflect that the respondent has many 
psychological strengths and resources for support (148). To generate results that are interpretable, the FS 
will be coded so that low scores represent flourishing and high scores represent languishing. The FS is a 
new measure developed based on contemporary theories of psychosocial wellbeing. This measure has 
been highly correlated to other measures of wellbeing (149). 
 
4.4.4 Student Covariates  
 Sociodemographic characteristics and modifiable risk factors are collected in the Cq from 
participating students. Key covariates will be included in the analysis to reduce potential for confounding. 
    
Sociodemographic Characteristics  
 Demographic characteristics to be included in the analysis are as follows: Grade (9, 10, 11, 12); 
sex (female, male); ethnicity (White, off-reserve Aboriginal, mixed/missing) and weekly spending money 
($0, $1-$20, $21-$100, more than $100, I don’t know). Weekly spending money is used as a proxy for 
socioeconomic status as this is a more accessible value for youth to report on than household income 
(116) and has been aggregated into these categories. Remaining congruous with other health behaviour 
research, these covariates were controlled for to reduce potential confounding.  
 
Modifiable Risk Factors 
Respondents were asked to report, “In the last 12 months, how often did you have five or more 
drinks of alcohol on one occasion?”. Consistent with previous research (2), those who responded binge 
drinking one or more times in the past month will be considered current binge drinkers in the analysis 
(non-current binge drinker=0, current binge drinker=1). Smoking status was assessed by asking 
respondents, “On how many of the last 30 days did you smoke one or more cigarettes”. Students who 
reported any 1 day or more will be considered current smokers (non-smoker=0, current smoker=1). 
Substance use items in the Cq were based on measures used in national surveys of youth substance use 
(136).  
 
4.5 Data Analysis  
 
The independent variables, depression and anxiety, will be coded as both continuous and 
categorical measures. The categorical measure will represent not having GAD or depression (absent=0) 
versus having GAD or depression (present=1). The continuous measure will represent the various levels 
of both mental illnesses and how cannabis use correlates respectively. Ever use of cannabis (dichotomous 
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dependent variable) will be fit using logistic models and these results will be the primary focus of this 
study. The frequency of cannabis use (ordinal dependent variable) will be fit using ordinal logistic 
regression models. The independent variables of interest will be fit as both dichotomous and continuous 
in two separate models to triangulate data and will be used primarily for a sensitivity analysis. Internal 
consistency values were calculated for the GAD-7 (α= 0.986) and the CES-D-10 (α= 0.983) to ensure 
good reliability of the mental health scales. 
 
Once all logistic regression models have been fit, flourishing will be included as a moderator to 
test whether cannabis use in correlation to depression and/or anxiety will differ based on the presence or 
absence of flourishing. Logistic regression analysis will be used to test flourishing as an interaction 
(moderator) variable (150). The moderation models will employ a single regression equation: 
 
Y = i5 + β1X + β2Z + β3XZ + e5 
 
β1 is the effect of depression and/or anxiety on cannabis use (when Z= 0); β2 is the effect of flourishing 
on cannabis use (when X = 0), β3 is the effect of the product of depression and/or anxiety and flourishing 
on cannabis use, i5 is the intercept and e5 is the residual in the equation. The regression coefficient (β3) 
provides an estimate of the effect flourishing; if β3 is found to be statistically different from zero, 
flourishing will significantly moderate the association between mental health and cannabis use (refer to 
Appendix B for diagram and description) (150).   
 
I used a stepwise modeling approach to build the final models that included 3 main steps. I 
evaluated both main effects, 2-way interaction and 3-way interaction effects for each of the 4 regression 
models. Each model followed a similar building strategy: 1) the main effects of depression and anxiety 
were tested, 2) flourishing was then added and main effects tested, and 3) the addition of 2-way and 3-
way interactions were included as the last step for the final model. Using a stepwise modeling approach, I 
was able to demonstrate and evaluate any changes in significance after adding variables and interactions, 
as well as supplement the interpretation of my results. A total of 12 logistic models were run. Models 1-3 
explored the association between cannabis ever use and dichotomized mental health variables, and models 
4-6 considered the same association using continuous mental health variables. Models 7-9 explored the 
association between the frequency of cannabis use and dichotomized mental health variables, and models 
10-12 considered the same association using continuous mental health variables.  Models 3, 6, 9 and 12 
represented the comprehensive model to include the 2-way and 3-way interactions. Concordance statistics 
(c-statistic) will be recorded to evaluate the goodness of fit for each model. High c-statistic values are 
22 
 
indicative of meaningful results and predictive value for the variables included (151). As the c-statistic 
increases or approaches 1.0, and the more likely models and variance within the analyses are explained 
not by random/chance and by the appropriate application of variables (151). 
 
4.5.1 Cannabis ever use and binary mental health variables  
For models 1-3, three binomial logistic regression models were conducted to assess if depression 
and/or anxiety was significantly associated with cannabis ever use. As well, I explored whether 
flourishing moderates cannabis use in students who indicate clinically relevant levels of depression and/or 
anxiety. I examined flourishing as a potential moderator within this association via 2-way and 3-way 
interactions. Independent and dependent variables were collapsed as dichotomous. All models controlled 
for student-level covariates (sex, grade, ethnicity, spending money, binge drinking and smoking). 
 
4.5.1.1 Model 1 
Model 1 explored how depression and anxiety (versus not) are associated with cannabis ever use, using a 
binomial logistic regression. This model analyzed depression and anxiety as dichotomous variables (0,1). 
 
 
4.5.1.2 Model 2 
Model 2 explored depression, anxiety and flourishing as the independent variables of interest and how 
they are associated with cannabis ever use, using a binomial logistic regression. Model 2 analyzed 
depression and anxiety as dichotomous variables. 
 
4.5.1.3 Model 3 
Model 3 explored 2-way and 3-way interactions (a total of 4 interaction terms) between depression, 
anxiety and flourishing, and how they are associated with cannabis ever use, using a binomial logistic 
regression. Model 3 analyzed depression and anxiety as dichotomous variables. 
 
4.5.2 Cannabis ever use and continuous mental health variables  
For models 4-6, three binomial logistic regression models were conducted to assess if depression 
and/or anxiety was significantly associated with cannabis ever use. As well, I explored flourishing as a 
potential moderator within this association via 2-way and 3-way interactions. Depression and anxiety was 





4.5.2.1 Model 4 
Model 4 explored how subtle differences in the level of depression and anxiety will impact cannabis ever 
use, using a binomial logistic regression where depression (0-30) and anxiety (0-21) were continuous 
variables. 
 
4.5.2.2 Model 5 
Model 5 explored how subtle differences in students’ level of depression, anxiety and flourishing will 
impact cannabis ever use, using a binomial logistic regression where depression and anxiety are 
continuous variables. 
 
4.5.2.3 Model 6 
Model 6 explored 2-way and 3-way interactions (a total of 4 interaction terms) between depression, 
anxiety and flourishing and how they are associated with cannabis ever use, using a binomial logistic 
regression. I fit depression and anxiety as both continuous variables. 
 
 
4.5.3  Frequency of cannabis use and binary mental health variables  
For models 7-9, three ordinal logistic regression models were conducted to assess if depression 
and/or anxiety was significantly associated with the frequency of cannabis use. Depression and anxiety 
were collapsed into dichotomous variables (0,1) and cannabis use frequency was coded as an ordinal 
variable (0,1,2,3,4). Models controlled for student-level covariates (sex, grade, ethnicity, spending money, 
binge drinking and smoking).  
 
4.5.3.1 Model 7 
An ordinal regression was fit for model 7, exploring the association between depression and anxiety, and 
cannabis use frequency. Model 7 analyzed depression and anxiety as a dichotomous variables. 
 
4.5.3.2 Model 8 
Model 8 explored depression, anxiety and flourishing as the independent variables of interest and how 
they were associated with the frequency of cannabis use, using an ordinal logistic regression. Model 8 






4.5.3.3 Model 9 
Model 9 explored 2-way and 3-way interactions (a total of 4 interaction terms) between depression, 
anxiety and flourishing and how they were associated with the frequency of cannabis use, using a 
binomial logistic regression. Model 9 analyzed depression and anxiety as dichotomous variables. 
 
4.5.4 Frequency of cannabis use and continuous mental health variables  
For models 10-12, three ordinal logistic regression models were conducted to assess if depression 
and/or anxiety was significantly associated with the frequency of cannabis use. Depression and anxiety 
were coded as continuous variables and cannabis use frequency as an ordinal variable (0,1,2,3,4). Models 
controlled for student-level covariates. 
 
4.5.4.1 Model 10 
Model 10 explored how subtle differences in the level of depression and anxiety will impact cannabis 
ever use, using a binomial logistic regression where depression (0-30) and anxiety (0-21) are continuous 
variables 
 
4.5.4.2 Model 11 
Model 11 explored how subtle differences in students’ level of depression, anxiety and flourishing will 
impact cannabis use frequency, using a binomial logistic regression where depression and anxiety are 
continuous variables. 
 
4.5.4.3 Model 12 
Model 12 explored 2-way and 3-way interactions (a total of 4 interaction terms) between depression, 
anxiety and flourishing and how they are associated with cannabis use frequency, using an ordinal logistic 





SECTION 5: Results 
  
5.1 Demographic Characteristics 
         In the large sample of youth, I identified that among grade 9-12 students, 33% of students 
reported ever using cannabis, and 7% were daily users. Clinically relevant symptoms of depression and 
anxiety (scores >/= 10) were reported by 51% and 38% of students, respectively, and showed increased 
prevalence in older grades. Co-occurring mental illness was common, as 86% of students who reported 
depression also reported having anxiety. The mean flourishing score was 16.6 (SD 5.87) and declined 
with grade level, suggesting that languishing may increase by grade. The majority of the sample reported 
their ethnicity as White (71.0%), and 50.8% of the sample reported their sex as female.  
 
5.1.1 Descriptive statistics by sex difference 
As shown in Table 1, females cannabis users were more likely to report sporadic use (18.0% 
versus 14.9%) and monthly use (7.7% versus 6.7%), while male cannabis users were more likely to report 
being weekly (4.2% versus 3.0%), habitual (2.6% versus 4.4%) or daily (4.3% versus 2.6%) cannabis 
users. Additionally, females more commonly reported depression (58.9%), anxiety (47.7%) and lower 
flourishing levels (mean 17.02) compared to males. Although still considerably high, males were less 
likely to report symptoms of depression (42.9%) and anxiety (28.1%), and indicated a better flourishing 
score average (mean 16.0 (SD 5.7)) compared to their female counterparts (mean 17.2 (SD 5.97)). 
Females were more likely to report higher levels of truancy (having skipped 1 or more classes in the last 4 
weeks) (41.7%) compared to males (38.8%). Males more commonly indicated a weekly spending 
allowance of either $0 or >$100 per week. There was no significant difference between males and 
females in cannabis ever use, smoking status, or binge drinking.  
 
5.1.2 Descriptive statistics by Depression 
 As shown in table 2, females more commonly reported symptoms of depression (58.6%) 
compared to males (41.4%). Depression was more common in all grade levels other than grade 9 (25.7% 
reported depression versus 30.2% reported no depression). Grade 10 students reported highest levels of 
depression (29.9%) and decreased in grade 11 (25.9%) and grade 12 (18.8%). Of the students who 
indicated having depression, majority reported being White (69.7%), skipping one or more classes a week 
(47.0%), smoking (14.5%), binge drinking (41.4%) and having anxiety (63.8%). Compared to those who 
reported no depression, students with depression also had lower flourishing (mean 19.14 [SD 6.09] versus 
mean 14.19 [SD 4.46]). Depression was significantly associated with cannabis ever use and all levels of 
cannabis use frequency. Students who met the criteria for depression were more likely to be cannabis ever 
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users (38.9% versus 25.9%) and report daily use (4.9% versus 1.9%), habitual use (2.5% versus 1.1%), 
weekly use (4.5% versus 2.7%), monthly use (8.8% versus 5.6%) and sporadic use (18.3% versus 14.6%).    
 
5.1.3 Descriptive statistics by Anxiety  
 As shown in table 3, clinically relevant symptoms of anxiety (referred to as anxiety) was more 
prevalent in females (63.7%) compared to males (36.3%). Anxiety was more common in all grade levels 
other than grade 9 (25.7% reported anxiety versus 30.2% reported no anxiety), whereby grade 10 students 
reported highest levels of anxiety (29.7%) and decreased in grade 11 (25.7%) and grade 12 (18.9%). Of 
the students who indicated having anxiety, majority reported being White (70.7%), skipping one or more 
classes (46.4%), smoking (15.1%), binge drinking (41.6%) and having depression (85.6%). Students who 
reported anxiety had lower flourishing (mean 19.53 [SD 6.38]) compared to students who did not met the 
criteria for anxiety (mean 14.99 [SD 4.84]). Students who met the criteria for anxiety were more 
commonly cannabis ever users (39.4% versus 28.3%) as well as, daily users (5.4% versus 2.2%), habitual 
users (2.4% versus 1.5%), weekly users (4.4% versus 3.2%), monthly users (9.1% versus 6.1%) and 
sporadic users (18.2% versus 15.4%).    
 
5.1.4 Descriptive statistics by Cannabis Ever Use 
         As shown in Table 4, prevalence of cannabis ever use increased with grade. Reported cannabis 
ever use was lowest among grade 9 students (14.4%), and the prevalence nearly doubled in grade 10 
students. Significantly large differences in smoking status, binge drinking, depression, and anxiety were 
reported between never users and ever users of cannabis. Compared to students who indicated never using 
cannabis, cannabis ever users were more likely to report smoking (29.4% versus 1.8%), binge drinking 
(75.5% versus 18.1%), symptoms of depression (61.0% versus 46.2%) and anxiety (46.1% versus 34.1%), 
as well as lower flourishing (mean 17.9 [SD 6.29] versus mean 16.0 [SD 5.55]). Moreover, cannabis users 
typically had higher weekly spending allowances and were more likely to report having skipped 1 or more 
classes a week (68.66% versus 26.59%). There were no significant differences by sex and provinces for 
cannabis ever use.  
 
5.1.5 Descriptive statistics by Frequency of Cannabis Use 
As shown in Table 5, frequency of reported cannabis use was found to typically increase with 
grade. Across cannabis use frequencies, the greatest jump in reported use occurred in grade 10 students 
with prevalence rates nearly doubled for all frequencies between grade 9 and 10. Prevalence of more 
frequent use continued to increase in grade 11 students and plateaued in grade 12. As frequency of 
reported cannabis use increased, students were at a greater risk for smoking and binge drinking, as well as 
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having poorer mental health outcomes. Compared to sporadic cannabis users, habitual users more 
commonly reported smoking (15.0% versus 58.2%), binge drinking (67.5% versus 85.7%), being 
depressed (56.5% versus 69.4%) and anxious (42.0% versus 49.0%) and lower flourishing (mean (17.2) 
versus mean (19.4)). Daily users of cannabis were the most likely to smoke (65.9%), binge drink (87.3%), 
report feelings of depression (72.9%) and anxiety (60.44%) and have the lowest mean flourishing score 
(20.8). I used an AVONA to measure significant differences between flourishing means for each level of 
cannabis use frequency. The normalcy of distribution was unclear, and therefore, both parametric and 
nonparametric tests were fit for further exploration. Both the ANOVA and Kruskal-Wallis test 
demonstrated statically significant differences in the means; ANOVA results were reported due to the test 
being more conventional in comparison (see Appendix E for additional analysis). As frequency of 
reported cannabis use increased, students were more likely to report being male, truancy and have greater 
spending allowances.  
 
5.2 Main effects and interactions 
The main effects and interactions were modeled using a stepwise approach. Models 1, 4, 7 and 10 
demonstrate the main effects of depression and anxiety, while models 2, 5, 8 and 11 were the same 
models inclusive of flourishing. Models 3, 6, 9 and 12 were the comprehensive models that included all 
interaction terms (i.e., the results of the main objectives). For all comprehensive models, flourishing was 
the only variable associated with cannabis ever use and frequency of use. After removing the 3-way 
interaction from the binary model, there were no changes in significance for the 2-way interactions. 
However, after removing flourishing as a main effect, I observed many changes in significance, whereby 
majority of the interactions had a significant effect confirming the expectation of flourishing as a third 
variable of interest (see Appendix E for additional analysis).  
  
5.2.1 Cannabis Ever Use with Binary Mental Health Outcomes (Models 1-3) 
The results of the stepwise models exploring cannabis ever use with binary mental health 
outcomes are presented in Table 6. The results for model 3 (comprehensive model) identified that for 
every one-unit increase on the flourishing scale (recall that higher scores reflect languishing), the 
likelihood of cannabis ever use significantly increases (B=0.040, SE=0.012). Although depression was 
found to be significant associated with cannabis ever use (B=0.281, SE=0.078) in model 1, after including 
flourishing in model 2 and 3, neither depression nor anxiety was significantly associated with cannabis 
ever use. This result was also observed for all 2-way and 3-way interactions included in model 3. Of the 
covariates included in model 3, absenteeism (OR=2.61), smoking (OR=9.83) and binge drinking 
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(OR=7.34) were found to be strong risk factors for cannabis ever use. Model 3 yielded a strong c-statistic 
(0.881), suggesting this is a good model. 
 
5.2.2 Cannabis Ever use with Continuous Mental Health Outcomes (Models 4-6) 
Table 7 presents the results of the stepwise models exploring cannabis ever use with continuous 
mental health outcomes. The results for model 6 (comprehensive model) demonstrates that for every unit 
increase on the flourishing scale, the likelihood of cannabis ever use significantly increases (B=0.048, 
SE=0.009). Depression and anxiety were not found to significantly predicted cannabis ever use. This was 
also observed for all 2-way and 3-way interactions included in model 6. Of the covariates included in 
model 6, absenteeism (OR=2.64), smoking (OR=10.07) and binge drinking (OR=7.33) were found to be 
strong risk factors for cannabis ever use. The c-statistic for model 6 was 0.881, demonstrating that the 
model is a good fit. 
  
5.2.3 Frequency of Cannabis Use with Binary Mental Health Outcomes (Models 7-9) 
Results for the stepwise models examining the frequency of cannabis use with binary mental 
health outcomes are shown in Table 8. The results of model 9 (comprehensive model) identified that 
every one-unit increase in languishing was significantly associated with an increase in the frequency of 
cannabis use (B=0.042, SE=0.010). While depression (B=0.286, SE=0.068) and anxiety (B=0.239, 
SE=0.068) were found to be significantly associated with the frequency of cannabis use in model 7, 
neither significantly predicted cannabis use after including flourishing in models 8 and 9. This was also 
observed for all 2-way and 3-way interactions included in model 9. Of the covariates included in model 9, 
absenteeism (OR=2.44), smoking (OR=7.32) and binge drinking (OR=6.94) were found to be strong risk 
factors for the frequency of cannabis use. Model 9 yielded a strong c-statistic (0.854), indicating much of 
the variance is explained and that the model was a good fit. 
 
5.2.4 Frequency of Cannabis Use with Continuous Mental Health Outcomes (Models 10-12) 
Table 9 presents the results of the stepwise models exploring the frequency of cannabis use with 
continuous mental health outcomes. The results for model 12 (comprehensive model) demonstrates that 
for every unit increase on the Flourishing Scale, the likelihood of cannabis ever use significantly increases 
(B=0.0513, SE=0.008). Similar to results from previous models, depression (B=0.002, SE=0.004) and 
anxiety (B=-0.001, SE=0.0061) was not associated with the frequency of cannabis use after including 
flourishing in the model and this was also observed for all 2-way and 3-way interactions included in 
model 12. Absenteeism (OR=2.46), smoking (OR=7.43) and binge drinking (OR=6.98) were found to be 
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strong risk factors for cannabis use frequency in model 12. The c-statistic for model 12 was 0.853, 
















SECTION 6: DISCUSSION 
 
The legalization of recreational cannabis use in Canada is expected to be implemented in late 
2018. Given these new regulations, there is a demand for research to identify at-risk populations and 
implement effective prevention programs to mitigate possible health consequences that may accompany 
the new legislation as mentioned previously. This study examined the association between mental health 
problems and cannabis use within high school students in Ontario and British Columbia, Canada. To the 
best of my knowledge, this thesis is the first study of its kind to evaluate indicators of mental wellbeing, 
such as flourishing, as a protective measure against cannabis use in youth with mental health problems. 
Overall, both cannabis use and mental health problems were found to be very common among youth in 
this thesis. Furthermore, these results suggest that higher flourishing is associated with lower cannabis use 
regardless of the presence or absence of mental health problems. The results of this study fill a knowledge 
gap within research, practice, and clinical domains, and may also present significant implications for 
innovative and universal prevention approaches to youth substance use. 
  
6.1 Cannabis use and mental health problems in Canadian youth 
Youth mental health problems and cannabis use are both highly prevalent and multifaceted public 
health issues. Half of the students in this pilot study scored above the accepted clinical threshold for 
symptoms of depression, and over one third for anxiety. Results indicated that depression, anxiety, and 
languishing all increased with grade level. As expected and consistent with previous research, students 
indicating symptoms of depression and anxiety were less likely to flourish, and females were more likely 
to experience symptoms of depression and anxiety than males (84). Additionally, this study identified that 
females tend to have lower levels of flourishing than males (84). Also consistent with previous research, 
this study found that males used cannabis at higher frequencies (e.g., weekly and daily) than females 
(152–156). Co-occurring depression and anxiety are highly prevalent in adolescent substance users, 
whereby use is typically more severe and problematic (157–160). Research shows that young drug users 
with mental health problems typically have greater morbidity related to mental illness and substance use 
as well as poorer quality of life compared to individuals with substance use problems exclusively (157). 
These findings demonstrate similar results, as the majority of youth (over three quarters) with depression 
also reported co-occurring anxiety. Moreover, cannabis use frequency was greater in individuals with co-





One third of the students in this sample had tried cannabis at least once and nearly 10% indicated 
using cannabis at least once a week. These findings align with other research (54,161) that suggests 
adolescence is the peak age for cannabis uptake, there was a significant increase in cannabis ever use 
observed between grade 9 and grade 12, and that older students used cannabis at higher frequencies. 
Depression and anxiety were also found to increase with grade. More specifically, this research identified 
the largest increase in depression, anxiety and cannabis use within grade 10 students. These high risk 
periods are important to take into account when developing prevention or intervention programs as 
individuals are impressionable and receptive to their environment (162). The findings presented in this 
thesis are consistent with other studies that have identified approximately one third of youth initiate 
cannabis use during adolescence (163), and further research shows that these individuals are at higher risk 
for developing a substance dependence than those initiating cannabis use later in life (164–166). The 
initiation of substance use early in life has been shown commonly to increase later in life and is associated 
with negative health, social and behavioural consequences (167). This suggests that the critical period for 
development of health behaviours and targeted interventions and prevention strategies might consider 
targeting students before grade 10, prior to initial cannabis uptake, to maximize resistance (168). 
  
6.2 Correlates of cannabis use in Canadian youth 
Consistent with both cross sectional and longitudinal research, this thesis found that youth who 
use cannabis were substantially more likely to engage in alcohol and tobacco use (169–171). On average, 
cannabis users were approximately 10 times more likely to smoke and 7 times more likely to binge drink. 
The frequency of cannabis use was directly related to tobacco smoking and binge drinking, with daily 
cannabis users being most likely to smoke and/or binge drink than all other cannabis users. My findings 
demonstrate a very strong correlation between these behaviours and suggest that risk-seeking behaviours 
might cluster. The strongest association of risky health behaviour clustering has been demonstrated in 
adolescent substance use literature (172), highlighting that these behaviours typically serve the same 
social and psychological function such as achieving adult status and acceptance from peers (173). Further, 
research has shown that risk behaviours cluster due to being from the same manifestation of related 
factors and is commonly a result of exposure to, and perception of various biological, individual, and 
environmental domains (173,174). A greater propensity for risk-seeking behaviours has been more 
commonly identified in males than in females (2,27,77,114), and it is therefore notable that no sex 





6.3 Flourishing as a significant third variable 
This research found that mental wellbeing was strongly associated with mental health problems 
and cannabis use. These findings are particularly novel, as they demonstrate that flourishing might 
mitigate potential negative associations between mental health problems and youth cannabis use. Results 
from this study demonstrate that students with high flourishing, regardless of mental health problems 
were less likely to use cannabis. Accordingly, languishing was found to be the strongest risk factor for 
cannabis use, outweighing even the influence of depression and anxiety. While most evidence suggests 
that there is a link between depression, anxiety, and cannabis use (5,33,51,129), the connection with 
flourishing/languishing has not been previously been established in the literature. And while mental 
health problems were found to be significantly correlated with cannabis use in some of my analyses, the 
stepwise modeling approach illustrated that these associations were no longer significant after including 
flourishing in the models. This suggests that flourishing may attenuate the effects of depression and 
anxiety on cannabis use, as previously demonstrated in the literature. Moreover, these results suggest that 
higher flourishing may result in lower cannabis use regardless of symptoms of depression or anxiety.  
 
6.4 Implications for Research 
Results suggest that flourishing may act as a dominant confounding variable in the association 
between depression, anxiety, and cannabis use. I am unaware of any research that has controlled for 
mental wellbeing when exploring this association, and therefore, available evidence may not represent 
accurate findings between cannabis use and depression and anxiety. Lastly, future longitudinal research is 
required to inform the temporal sequence and the direction of effect between mental health and cannabis 
use. 
 
6.4.1 Differential Susceptibility Framework 
The differential susceptibility model was used to assess how individuals differ in their response or 
sensitivity to exposed environments (175,176). This framework was used as a theoretical framework to 
help guide my study design, examining both positive and negative affect in cannabis use patterns. Using 
depression and anxiety as measures of vulnerability and flourishing as a stress factor, my data did not 
support the differential susceptibility framework as there were no interactions (2-way or 3-way) observed 




6.4.2 Confounding effects of flourishing 
There were no associations or interactions found between mental health problems and cannabis 
use, contrary to previous research. I hypothesized there would be an association between mental health 
problems and cannabis use and for this to be moderated by flourishing. However, since there were no 
significant interactions identified in the analyses, my hypotheses were not supported. A moderator is a 
third variable that affects the association between the dependent and independent variables (150), and is 
typically observed as an interaction between the variables included within the analysis (150). As there 
were no significant interactions identified in my analysis, I concluded that flourishing is not a moderator. 
In support of this finding, flourishing was found to have a significant effect on both depression and 
anxiety (independent variables) as well as cannabis use (dependent variable), which is typical of a 
confounding variable. As such, flourishing would not be considered a moderator in this study, rather a 
major confounder given its influence on both the exposure and outcome variables and not solely the 
correlation between them (see appendix B for a pathway illustration of both moderating and confounding 
variables). 
 
Although this study was the first to explore the association between mental health and substance 
use while controlling for flourishing, positive wellbeing has been identified as an important variable in the 
prevention of substance use. For example, flourishing and other constructs of positive mental health have 
been recognized by global research centers, such as the Centre for Addiction and Mental Health (177) and 
the Mental Health Commission of Canada (178) as important individual protective factors against youth 
substance use. Current research on cannabis use and mental health may not represent accurate findings as 
flourishing or other indicators have not been previously controlled for, and as such, should consider 
replicating previous studies within this domain if measures are available. Future research and large scale 
epidemiological studies should aim to measure and control for indicators of positive mental health and 
test for confounding effects in other substance use research including alcohol and tobacco given its highly 
influential effects observed in the results of this thesis. 
 
6.4.3 Longitudinal analysis 
While this study identified a cross-sectional association, future studies should explore the casual 
relationship between mental health problems and cannabis use, as well as the role of flourishing over 
time. As demonstrated in this study and by other research, co-occurring mental health problems and 
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substance use disorders are highly prevalent (157,158), however, the direction of effect is not well 
understood. There would be great value in having a clear understanding of the causal relationship between 
cannabis use and mental health problems and future longitudinal work may want to consider using path 
analyses, such as a cross-lag panel modeling, to identify the sequential relationship if one exists as well as 
the possible direction of effect. This is now possible with COMPASS, which has incorporated the MH-M 
in all wave 6 (Y6[2017-2018]) data collections. Future longitudinal research might also explore the effect 
of flourishing on other substance use domains including tobacco and alcohol. As cannabis use has been 
found to increase with age (2,114), following youth into young adulthood would also provide valuable 
insight for prevention and intervention programs that are targeted at an older population, such as 
university and college students.  
 
The gateway hypothesis describes the theory that adolescents initial engagement with tobacco, 
alcohol, and cannabis, could lead to experimentation with more addictive illicit drugs over time (179). 
Studies exploring this theory have demonstrated mixed and inconclusive results (7,180–182). COMPASS 
provides an ideal platform to evaluate the gateway hypothesis, and identify potential gateway substances 
or individual constructs (e.g., socio-emotional skills, self-regulation, and impulse control) that may be 
related to the proposed gateway effect. On account of the impending legalization of cannabis, Canada is 
currently undergoing a natural experiment at the national level, and as such, there is a demand for 
research focused on youth cannabis use. Evidence within this domain is currently limited and research 
platforms that have collected longitudinal data pre- and post-legalization of cannabis will be paramount in 
evaluating the resulting advantages and consequences. In addition to this nation-wide experiment, 
provinces have adopted their own set of guidelines to supplement federal requirements allowing for 
evaluation of cross-provincial and national comparisons of cannabis prevalence and effective laws and 
policies. This research will be important to assess various approaches and make decisions on best practice 
and public health safety standards by evaluating lowest risk use. 
 
6.5 Implications for Practice and Prevention 
Flourishing was found to be protective against substance use for all youth regardless of 
depression or anxiety symptoms. Findings relating to flourishing are novel as overall wellbeing had a 
ubiquitous effect on preventing cannabis use regardless of mental health problems. These results 
compliment recent literature that highlights the importance of a universal approach for reducing cannabis 
use in a youth population (183–185). Research has demonstrated that traditional interventions promoting 
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abstinence from substance use are not effective (186,187). Instead, research should focus on prevention 
programs that do not inherently target substance use, rather upstream protective factors such as 
flourishing and resilience, that contribute to overall wellbeing. Researchers expect cannabis uptake in 
Canadian youth to initially increase, following a similar trajectory to what has been observed in other 
jurisdictions (e.g. Colorado, Washington State) that have legalized cannabis (2–4), and as such, further 
examination of how flourishing is related to substance use trajectories will produce valuable prevention 
planning insight moving forward. 
 
6.5.1 Universal programs and school-based prevention strategies  
Universal prevention strategies are designed to be implemented at the population-level, providing 
the necessary knowledge and skills to prevent negative health behaviours, instead of targeting individual 
risk factors. These findings suggest that a universal approach to fostering mental wellbeing and building 
resilience among all youth should be a leading priority, and may be more effective at reducing substance 
use than intervention strategies targeting individuals with mental illness. This is consistent with other 
research domains showing that population-level programs supporting the development of life skills and 
psychosocial attributes, have been found to be highly effective at reducing substance use (186,188,189). 
Elementary and secondary schools might be one such environment to support the development of these 
skills and have the potential to reach majority of youth, as this is where more than half of their waking 
hours are spent.  These strategies have the potential to reach the majority of youth and alter the school 
environment, which has previously been identified as an important setting to modify substance use 
behaviours (190) and promote overall wellbeing among youth (191). Positive school experiences 
including rewarding relationships with teachers and academic engagement have been linked to better 
mental health outcomes (191). Positive school experiences have even been found to improve mental 
health among students exposed to maltreatment in childhood (191). 
  
A systematic review of universal, school-based substance use interventions demonstrated that 
intervention type, approach, and setting, are important for long-term results (188). Interventions were 
most effective when addressing resilient-protective factors as part of a multidimensional intervention 
approach that targeted broader individual resilience factors such as, social, emotional and cognitive 
competencies, self-efficacy and regulation, academic achievement. This study also identified 
environmental resilience factors (e.g., school connectedness, community participation and support, parent 
support and involvement) to be very effective at reducing substance use (188). The same long-term 
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effects were seen in universal-only approaches as well as interventions that were implemented within a 
school setting, illustrating the importance of using the school environment as a platform for these 
programs (188). One study assigned a community-based, universal drug prevention strategy to randomly 
selected public schools in Iowa and Pennsylvania, U.S.A (192). The study implemented family-focused 
interventions within grade 6 and 7 classrooms that focused on developing peer-resistance, self-
management, and social skills, preventing social influence and strengthening family dynamics. The 
community-based intervention demonstrated long-term effects on both the initiation and past –year use of 
cannabis and intervention effects were stronger for high risk students (192). COMPASS has the unique 
ability to identify naturally occurring student health behaviours and environmental changes over time, and 
allows for the implementation of school-based intervention programs targeting these issues. This research 
system provides the capacity to implement evidence-based universal programs at the school-level with the 
opportunity to evaluate.    
 
6.5.2 Clinical-based implications 
These results demonstrate the importance of fostering good mental wellbeing to mitigate the use 
and misuse of cannabis in secondary school students. There would be great value in replicating this study 
on other substance use outcomes, and using clinical-based data that uses true diagnostic criteria for mental 
disorders. This type of research could help inform clinical approaches that may be effective when 
considering individual and personality targeted interventions. Personality-targeted interventions that 
include a personality assessment to determine substance use risk factors, allow for tailored intervention 
strategies that correspond to specific traits and have been effective at reducing cannabis use within high-
risk adolescents (193). A study conducted in UK secondary schools found that targeted-interventions that 
provide personality-specific coping skills resulted in significant reductions of cannabis use among high-
risk youth after a 2-year follow-up (193). Prevention-intervention approaches used within this study 
included sessions that promoted positive coping behaviours and goal-setting, as well as evaluating 
cognitive-behavioural components. Because of the resources and training that were required for school 
staff, this approach may be more appropriately implemented at the clinical level. Research should 
continue to reference previous studies that have explored domains similar to flourishing such as 






SECTION 7: STRENGTHS AND LIMITATIONS 
 
It is important to note that this study is not without limitations. First, my results were cross-
sectional, and as such, causality and temporality cannot be inferred. However, given the nature of the pilot 
study, an initial cross-sectional analysis was necessary to understand the prevalence of mental health 
problems and provide direction for future longitudinal studies using data from the COMPASS MH-M. 
COMPASS uses a convenience sample and was therefore not designed to be nationally representative. 
While the collected data may not be generalizable to all youth, sufficient sample size and power was 
provided to detect a correlation. 
  
All measures included in the analyses were self-reported and are subject to social desirability bias 
and recall bias.  It is possible that students will be erroneous when recalling past-year cannabis use 
frequency and may under-or over-report their cannabis use as accuracy depends on their ability to 
remember past use (194). Additionally, evidence suggests that self-reported depressive symptoms, mental 
health problems and substance use behaviours can be underreported if participants are influenced by 
stigma and social desirability (195). These biases mentioned could lead to potential misclassification of 
both the exposure and outcome, therefore underestimating the association between depression, anxiety, 
flourishing and cannabis use in youth.  Another limitation is that of missing data, which might be due to 
students’ discomfort reporting mental health problems or cannabis use. By employing a complete-case 
analysis, the results could underestimate the true association, as unreported or missing data may be more 
likely among students with mental health problems and those who use cannabis. To account for biases 
that accompany self-reported measures, COMPASS ensures confidentiality of data through anonymized 
student surveys and utilizes a passive consent protocol to reduce the effects of information bias (social 
desirability and recall bias) and missing data. 
 
  While self-reported data does come with limitations, mental health (146,147) and cannabis use 
measures included in the analyses are consistent with previously validated self-reported measure among 
youth and measures used in national survey systems such as the Youth Smoking Survey (YSS) (136). It is 
important to note that mental health data were measured using scales and not diagnostic criteria. It is 
expected that the scales used to measure symptoms of mental health problems (CES-D-10 and GAD-7) 
will yield higher results than what exists within the general population. Despite this, research has 
38 
 
demonstrated that the mode of data collection is important for collecting reliable and unbiased data; self-
administered surveys or checklists typically produce valuable and truthful results when compared to 
telephone surveys or face-to-face interviews where participant may account for social norms and 
responses reflect more socially desirable answers (196). Moreover, self-administered surveys are 
necessary for large school-based studies and research platforms such as COMPASS as diagnostic 




SECTION 8: CONCLUSIONS 
  
Youth mental health and cannabis use are leading public health concerns in Canada, especially 
given the impending legalization of cannabis. Researchers expect cannabis uptake in Canadian youth to 
increase, following a similar trend to what has been observed in other countries and states that have 
legalized cannabis use. This study supplements what is known about cannabis use in adolescents, as it was 
found to be highly prevalent and increased with age, consistent with previous research. Despite existing 
evidence that has demonstrated a relationship between mental health problems and cannabis use, there were 
no significant correlations between depression, anxiety and cannabis use found within this large sample of 
youth. Indicators of mental wellbeing, such as flourishing, appear to be associated with a lower likelihood 
of cannabis use, even after controlling for depression and anxiety. A greater understanding of the context 
in which cannabis uptake develops will help inform future research, policies and programs that can 
effectively reduce or prevent substance use in youth. Prevention strategies for youth cannabis use should 
aim to foster mental wellbeing among all youth, rather than exclusively targeting those experiencing mental 
health problems, and the school environment offers an important setting with large breadth to intervene. If 
available, future analyses might consider including additional measures such as parental factors (e.g., parent 
education, support and involvement), other risk seeking behaviours (e.g., gambling) and sexual health, as 
well as exploring this relationship over time. Future longitudinal studies should test the sequential 
relationship between cannabis use and mental health and explore how flourishing is related to different 
substance use trajectories, in order to better inform future policy and prevention programs. The relationship 
between mental health problems and cannabis use is not well understood and employing methods such as 
a cross-lag analysis may provide more context to the direction of causality. The COMPASS System 
provides an ideal platform to examine this relationship over time and allows researchers to evaluate the 
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APPENDIX B: Diagrams  




The mental illness continua runs from severe mental illness to no mental illness and intersects with the 
mental health continua that runs from good mental health to poor mental health. This therefore shows that 
a person with without mental illness is not necessary mentally healthy (languishing) due to environmental 
factors such as stress for an example. Moreover, a person with mental illness can still have good mental 
health (flourishing) and can exhibit a high emotional, psychological and social wellbeing with the right 

















The pathway of a moderating variable is demonstrated in the diagram above. C1 is the effect of 
depression and/or anxiety on cannabis use (when Z= 0); C2 is the effect of flourishing on cannabis use 
(when X = 0), C3 is the effect of the product of depression and/or anxiety and flourishing on cannabis 
use, i5 is the intercept and e5 is the residual in the equation. The regression coefficient, C3, provides an 
estimate of the effect flourishing via an interaction; if β3 is found to be statistically different from zero, 
flourishing will significantly moderate the association between mental health and cannabis use (150).  A 




The image above illustrates the pathway of a confounding variable. Confounding is classified as a 
variable that influences both the exposure and outcome variables and not solely the correlation between 
them. For a variable to be considered a confounder, it must be associated with the exposure (unequally 
distributed between exposed and nonexposed) and outcome of interest (usually as a risk factor) and it 
must not be and effect of the exposure or interact with the causal pathway (197).   
APPENDIX C: Tables  
Y= dependent variable 
(cannabis use) 
X=independent variable 
(depression and/or anxiety) 
Z=moderator (flourishing) 
XZ=product of independent 
variable and the moderator 
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Table 1. Sample Descriptive by Sex * 
*Complete case analysis only. Students with missing data for sex, grade and cannabis use were removed from 
analysis  
**Numbers may not add to total sample due to missing data  








































Province  Ontario 



















26.4 (1038)  
23.3 (917)  
21.6 (847)  
11.1 (437)  
64.18,  <0.001 
Truancy  No skipped class  













Binge Drinking Non-binge drinker 

















No Anxiety  





















 32.7 (1293) 
0.05,  0.83 
Cannabis Use ** Never Use 
Sporadic/Rare Use   
Monthly Use 
Weekly Use 
Habitual use  
















Table 2. Sample Descriptive by Symptoms of Depression (Binary Outcomes) 
 
*Numbers may not add to total sample due to missing data  
  



























X2 =41.43,  
df= 3,  
p< 0.0001 


















X2 =14.72, df= 
5,  
P=0.0116 
Province  Ontario 


























X2 =2.993, df= 
1,  
P=0.559 
Truancy  No skipped class  



























X2 =79.92, df= 
1, 
p< 0.0001 




























Sporadic/Rare Use   
Monthly Use 
Weekly Use 
Habitual use  


















Table 3. Sample Descriptive by Symptoms of Anxiety (Binary Outcomes) 
 
*Numbers may not add to total sample due to missing data  




























df= 3,  
p< 0.0001 



















df= 5,  
p< 0.0455 
Province  Ontario 


























X2 =5.17, df= 
4,  
p< 0.2705 
Truancy  No skipped class  




























df= 1,  
p< 0.0001 











Mean Score (SD) 14.99 (4.84) 
 

















Sporadic/Rare Use   
Monthly Use 
Weekly Use 
Habitual use   


































  % (n) % (n) % (n) Test Statistic, P-
value 




















































Province  Ontario 
































Truancy  No skipped class  











































No Anxiety  











Mean Score (SD) 16.6 (5.87) 16.0 (5.55) 17.9 (6.29) -13.57, <0.001 
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Table 5. Sample Descriptive by Frequency of Cannabis Use 





































































































Province  Ontario 




















































Truancy  No skipped class  





























Binge Drinking Non-binge drinker 































Anxiety (GAD-7) No Anxiety  


























56.43, <0.001  
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Table 6. Cannabis Ever Use for grade 9-12 students in year 5 of the mental health pilot of COMPASS (using 
depression and anxiety threshold measures) 
 





and Flourishing  
Model 3 
2-way and 3-way 
interactions (final 
model) 








































































Truancy  No skipped class  









































No Anxiety  









  0.033 (0.007)** 0.040 (0.012)* 
Interactions    B(SE) 
Dep*Anx     1.297 (0.628) 
Dep*Flourish    0.009 (0.019) 
Anx*Flourish    0.031 (0.033) 
Dep*Anx*Fl
ourish 
   -0.065 (0.038) 
 Concordance statistic  0.881 0.880 0.881 






Table 7. Cannabis Ever Use for grade 9-12 students in year 5 of the mental health pilot of COMPASS (using mental 
health continuous scores) 
 








2-way and 3-way 
interactions (final 
model) 








































































Truancy  No skipped class  




























Main Effects  B(SE) B(SE) B(SE) 
Depression 
(Dep) 
 0.001 (0.001) 0.00004 (0.001) 0.006 (0.004) 
Anxiety 
(Anx) 
 0.002 (0.001) 0.001 (0.002) 0.0001 (0.007) 
Flourishing 
(Flourish) 
  0.041 (0.006)** 0.048 (0.009)** 
Interactions    B(SE) 
Dep*Anx     0.00004 (0.0001) 
Dep*Flourish    -0.0003 (0.0003) 
Anx*Flourish    0.0001 (0.0004) 
Dep*Anx*Flo
urish 
   -3.77E-6 (5.92E-6) 
 Concordance statistic  0.879 0.880 0.853 
* p≤0.01, **p<0.001 
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Table 8. Frequency of Cannabis Use for grade 9-12 students in year 5 of the mental health pilot of COMPASS 
(using depressive and anxiety threshold measures) 
 








2-way and 3-way 
interactions (final 
model) 








































































Truancy  No skipped class  




















































  0.039 (0.005)** 0.042 (0.010)** 
Interactions    B(SE) 
Dep*Anx     0.649 (0.536) 
Dep*Flouris
h 
   -0.004 (0.016) 
Anx*Flouris
h 
   0.028 (0.028) 
Dep*Anx*Fl
ourish 
   -0.032 (0.032) 
 Concordance statistic  0.852 0.853 0.854 
* p≤0.01, **p<0.001 
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Table 9. Frequency of Cannabis Use for grade 9-12 students in year 5 of the mental health pilot of COMPASS 
(using mental health continuous scores) 
 







Model 12  
2-way and 3-way 
interactions (final 
model) 








































































Truancy  No skipped class  



























Main Effects  B(SE) B(SE) B(SE) 
Depression 
(Dep) 
 0.001 (0.001) 0.001 (0.001) 0.002 (0.004) 
Anxiety 
(Anx) 
 0.002 (0.001) 0.0002 (0.001) -0.001 (0.006) 
Flourishing 
(Flourish) 
  0.047 (0.005)** 0.0513 (0.008)** 
Interactions    B(SE) 
Dep*Anx     0.001(0.001) 
Dep*Flourish    -0.0001(0.0002) 
Anx*Flourish    0.0001(0.0003) 
Dep*Anx*Flo
urish 
   -4.9E-6 (4.8E-6) 
 Concordance statistic  0.849 0.853 0.853 






APPENDIX D: Figures 
 























Kruskal-Wallis Test  
Chi-Square 208.5029 
DF 5 






















1 5113 2344.71630 2556.50 19.164259 0.458579 
2 1273 702.08652 636.50 15.304702 0.551521 
4 267 170.03823 133.50 7.548152 0.636847 
5 134 89.25956 67.00 5.395794 0.666116 
6 238 164.80080 119.00 7.140585 0.692440 
3 547 315.09859 273.50 10.594774 0.576049 
Average 
scores were 
used for ties.      
 
 
Median One-Way Analysis  
Chi-Square 148.4107 
DF 5 








Class Level Information   
Class Levels Values 










7572     
Source DF 
Sum of 
Squares Mean Square F Value Pr > F 
Model 5 9374.4689 1874.8938 56.43 <.0001 
Error 7566 251394.5268 33.2269   
Corrected 
Total 
7571 260768.9956    
 
 
R-Square Coeff Var Root MSE FLOURISH Mean 
0.035949 34.66614 5.764276 16.62797 
 
 
Source DF Anova SS Mean Square F Value Pr > F 




Level of CAN_ORD N 
FLOURISH  
Mean Std Dev 
1 5113 16.0007823 5.54530347 
2 1273 17.2065986 5.75062647 
3 547 17.6234004 5.75068406 
4 267 18.6816479 6.19602713 
5 134 19.4328358 7.19591338 













Estimates        
Paramete














 1 0.2194 0.2808 0.6105 0.4346 
FLOURI
SH 
  1 0.0466 0.0112 17.4086 <.0001 
GAD7_BI
N 
















Anxiety  1 -0.0194 0.0157 1.5377 0.2150 
MALE male  1 0.1174 0.0703 2.7948 0.0946 
GRADE1
0 
0  1 -0.4669 0.0993 22.0955 <.0001 
GRADE1
1 
0  1 -0.6466 0.1023 39.9766 <.0001 
GRADE1
2 
0  1 -0.6863 0.1094 39.3584 <.0001 




 1 0.9585 0.0692 192.0338 <.0001 
PROV BC  1 0.3672 0.0704 27.2242 <.0001 
WKLY_S
PEND 





21-100$  1 0.4309 0.1193 13.0452 0.0003 
WKLY_S
PEND 
>100$  1 0.5821 0.1240 22.0465 <.0001 
WKLY_S
PEND 
IDK  1 0.2056 0.1399 2.1595 0.1417 
ETHNIC Aborigin
al 
 1 0.7014 0.2298 9.3183 0.0023 
ETHNIC Asian  1 -1.1011 0.1456 57.1837 <.0001 




 1 -0.0948 0.2059 0.2120 0.6452 
ETHNIC Other/M
ixed 
 1 0.0272 0.1077 0.0636 0.8009 
SMOKE_
BIN 
































Estimates        
Paramete














 1 -0.6159 0.2766 4.9597 0.0259 
GAD7_BI
N 






















Anxiety  1 0.0708 0.0313 5.1264 0.0236 
MALE male  1 0.1195 0.0701 2.9033 0.0884 
GRADE1
0 
0  1 -0.4607 0.0991 21.6093 <.0001 
GRADE1
1 
0  1 -0.6501 0.1021 40.5436 <.0001 
GRADE1
2 
0  1 -0.6859 0.1092 39.4340 <.0001 




 1 0.9729 0.0690 198.6229 <.0001 
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PROV BC  1 0.3632 0.0703 26.6956 <.0001 
WKLY_S
PEND 
1-20$  1 0.2513 0.1206 4.3430 0.0372 
WKLY_S
PEND 
21-100$  1 0.4039 0.1188 11.5477 0.0007 
WKLY_S
PEND 
>100$  1 0.5606 0.1236 20.5594 <.0001 
WKLY_S
PEND 
IDK  1 0.1901 0.1397 1.8504 0.1737 
ETHNIC Aborigin
al 
 1 0.7001 0.2291 9.3380 0.0022 
ETHNIC Asian  1 -1.0845 0.1459 55.2568 <.0001 




 1 -0.0874 0.2051 0.1817 0.6699 
ETHNIC Other/M
ixed 
 1 0.0303 0.1079 0.0788 0.7789 
SMOKE_
BIN 





 1 1.9842 0.0696 812.1189 <.0001 
 
